House of Technologies Home of Entrepreneurs Blankett för frivillig inlösen Annual Report 2016 News 10 Oct Xbrane Biopharma AB appoints Dina Jurman, Head of Clinical Affairs, to management team Xbrane Biopharma AB (publ) has appointed Dina Jurman, Head of Clinical Affairs at Xbrane, to its management team. […] 09 Oct Episurf Medical will exhibit at the Norwegian Orthopaedic Society’s Autumn Meeting 2017, held in Oslo, Norway, on October 25-27 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Norwegian Orthopaedic Society’s Autumn Meeting 2017, held in Oslo, […] 09 Oct Episurf Medical will exhibit at the Danish Orthopaedic Society’s Congress 2017, held in Copenhagen, Denmark, on October 26-28 Episurf Medical (NASDAQ: EPIS B) will exhibit at the Danish Orthopaedic Society’s Congress 2017, held in Copenhagen, Denmark […] 06 Oct Members of the Nomination Committee for Episurf Medical’s Annual General Meeting in 2018 In accordance with decision by the Annual General Meeting, Episurf Medical’s Nomination Committee shall consist of four members. […] view more news Serendipity Ixora At Serendipity, we are proud of our heritage and we embrace our serendipitous beginnings. So much so, that it is a fundamental element in our philosophy and the way we work. For more than a decade, Serendipity has focused on transforming cutting edge technologies into products and services that bring value to the world. Ranging from environmentally friendly alternatives to existing products to novel products that pave the way and set new standards in their respective fields, we seek to build sustainable businesses with global markets. Net Asset Value per Share Date: 30/09-17 161,8SEK Net Asset Value Date: 30/09-17 860MSEK Events 18 Sep Extra Bolagsstämma Serendipity Ixora 18 september 2017 Varmt välkommen till extra bolagsstämma i Serendipity Ixora . Datum: Måndagen den 18 september 2017 Tid: Kl. 17:30, registrering öppnar klockan […] 19 Apr Informations- och uppdateringsseminarium 19 april 2017 Varmt välkommen till Serendipity Ixoras informations- och uppdateringsseminarium som äger rum onsdagen den 19 april 2017. Platsen för seminariet är […] 07 Jun Årsstämma 2017 Serendiptiy Ixoras Årsstämma hölls den 7 juni 2017 Datum: Onsdagen den 7 juni 2017 Tid: Kl. 18:00, registrering öppnar […] view more events Investment Philosophy We identify, develop, and invest in leading innovative technologies and companies with the ability to make global impact on societal and industrial grand challenges. As such, our portfolio companies combine disruptive technologies and trends with strong and competent teams aiming for global markets. Each new investment is evaluated in terms of market potential, scalability, distinct competitive advantage, high differentiation, strong leadership, and the ability to deliver high margins over time. We build to keep. Therefore we have no explicit exit strategy, provided that the company continues to generate growth in line with our targets. COMPANY INFO INFO@SERENDIPITY.SE STUREPLAN 15 SE-111 45 STOCKHOLM SWEDEN PORTFOLIO COMPANIES DIAMORPH EPISURF MEDICAL ORGANOCLICK IRRAS PREMUNE SWECURE XBRANE BIOPHARMA VOFF SCIENCE Copyright All Rights Reserved © 2015